| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.2 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |